Literature DB >> 10906277

Protein degradation in MHC class II antigen presentation: opportunities for immunomodulation.

P G Medd1, B M Chain.   

Abstract

Proteolysis is required for two steps of the MHC class II antigen-processing pathway, degradation of invariant chain and cleavage of protein antigens. Invariant chain dissociation from MHC is limited by a final proteolytic event which is tightly regulated in both temporal and tissue-specific ways. In contrast, enzymes involved in antigen proteolysis remain ill-defined. Gene 'knockout' experiments of housekeeping proteolytic enzymes suggest either that these enzymes do not play a major role, or that antigen proteolysis is too degenerate for this type of analysis. The possible role of two other proteinases, cathepsin E and aspariginyl endopeptidase is discussed. Finally, the data implicating antigen processing in repertoire generation is briefly considered. We conclude that selective regulation of endosomal proteolysis could have profound implications for control of immunity against infection, as well as in autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906277     DOI: 10.1006/scdb.2000.0162

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  10 in total

1.  Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner.

Authors:  Joanna M Rybicka; Dale R Balce; Sibapriya Chaudhuri; Euan R O Allan; Robin M Yates
Journal:  EMBO J       Date:  2011-12-13       Impact factor: 11.598

2.  Cysteine protease inhibitor of Schistosoma japonicum - A parasite-derived negative immunoregulatory factor.

Authors:  Lin Chen; Baohua He; Wei Hou; Li He
Journal:  Parasitol Res       Date:  2017-01-09       Impact factor: 2.289

Review 3.  Messenger RNA (mRNA) nanoparticle tumour vaccination.

Authors:  Kyle K L Phua; Smita K Nair; Kam W Leong
Journal:  Nanoscale       Date:  2014-07-21       Impact factor: 7.790

4.  Parasite-specific immunomodulatory functions of filarial cystatin.

Authors:  Peter Schierack; Richard Lucius; Bettina Sonnenburg; Klaus Schilling; Susanne Hartmann
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Recognition of Class II MHC Peptide Ligands That Contain β-Amino Acids.

Authors:  Ross W Cheloha; Andrew W Woodham; Djenet Bousbaine; Tong Wang; Shi Liu; John Sidney; Alessandro Sette; Samuel H Gellman; Hidde L Ploegh
Journal:  J Immunol       Date:  2019-08-07       Impact factor: 5.422

6.  Structural and functional studies of legumain-mycocypin complexes revealed a competitive, exosite-regulated mode of interaction.

Authors:  Tasneem Elamin; Naiá P Santos; Peter Briza; Hans Brandstetter; Elfriede Dall
Journal:  J Biol Chem       Date:  2022-09-15       Impact factor: 5.486

7.  Modulation of dendritic cell function and immune response by cysteine protease inhibitor from murine nematode parasite Heligmosomoides polygyrus.

Authors:  Yanxia Sun; Guiyun Liu; Zhaotao Li; Yue Chen; Yunfeng Liu; Boyu Liu; Zhong Su
Journal:  Immunology       Date:  2013-04       Impact factor: 7.397

8.  Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells.

Authors:  Chinnaswamy Jagannath; Devin R Lindsey; Subramanian Dhandayuthapani; Yi Xu; Robert L Hunter; N Tony Eissa
Journal:  Nat Med       Date:  2009-03-01       Impact factor: 53.440

9.  Targeted delivery of antigen processing inhibitors to antigen presenting cells via mannose receptors.

Authors:  Benjamin M Chain; Alethea B Tabor; Eun-Ang Raiber; Calogero Tulone; Yanjing Zhang; Luisa Martinez-Pomares; Emily Steed; Anna M Sponaas; Jean Langhorne; Mahdad Noursadeghi
Journal:  ACS Chem Biol       Date:  2010-05-21       Impact factor: 5.100

10.  Bioinformatics analysis and characterization of a secretory cystatin from Thelohanellus kitauei.

Authors:  Fengli Zhang; Yalin Yang; Chenchen Gao; Yuanyuan Yao; Rui Xia; Juan Hu; Chao Ran; Zhen Zhang; Zhigang Zhou
Journal:  AMB Express       Date:  2020-06-23       Impact factor: 3.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.